Specialty Pharmacy

MicroRNA clusters may influence immune cell generation.

Caucasians found to have better skin cancer survival rates.

Top news of the day from across the health care landscape.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology, and cancer drug development.

Researchers explore harnessing power of immune system to kill HIV.

The confidence of pharmacists dispensing biosimilars along with varying opinions on naming conventions influence uptake of interchangeable biologic drugs.

Wide range of prescription drugs drive lowest fertility levels in more than a century.

Top news of the day from across the health care landscape.

Discovery may help tumor suppression on a molecular level.

HIV-positive men were more likely to have increased levels of inflammatory biomarkers than HIV-negative men.

Advance in lung cancer therapy achieved on molecular level.

Top news of the week on Specialty Pharmacy Times.

Mark Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses the impact of growing copay costs for patients on medication adherence.

Liver stiffness drops through sustained virological response at 24 weeks with hepatitis C antiviral drug regimen.

Xbox One Kinect platform shown to be effective helping walking gait issues in patient with multiple sclerosis.

Fevipiprant significantly decreased asthma symptoms.

Study finds use of digital health care platforms among growing population of senior citizens needs to improve.

Top news of the day from across the health care landscape.

Research analyzes HIV-positive individuals who naturally produce broadly neutralizing antibodies.

Caregivers need to encourage patients fearful of life-saving tests for cancer.

Drug to be evaluated combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Ribociclib seeking indication for use in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Specialty pharmacies must engage each individual patient to ensure optimal treatment outcomes.

Early treatment for multiple sclerosis found to delay relapse.

Improving data analytics could significantly speed up medical advances.

Sophisticated computer model illustrates that stopping hepatitis C within a single US state is a daunting task.

Group of molecules may present target to slow tumor growth in prostate cancer.